{"schema_version":"1","generated_at":"2026-11-04T20:09:53.392Z","data_as_of":null,"url":"https://www.findmykol.com/kol/whitney-hensing","json_url":"https://www.findmykol.com/kol/whitney-hensing/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"whitney-hensing","name":"Whitney Hensing","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Washington University in St. Louis","institution_url":"https://www.findmykol.com/institution/washington-university-school-of-medicine-in-st-louis","city":"Kansas City","state":"MO","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1760832711","orcid":"0009-0006-4486-1875","openalex":"A5073249530"},"summary":"Whitney Hensing is an Oncology physician affiliated with Washington University in St. Louis. OpenAlex indexes 44 publications with 224 citations (h-index 9); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":44,"cited_by_count":224,"h_index":9,"latest_activity_year":2025,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT05275361","title":"Utilizing Social Contacts to Facilitate Mammogram Screening Among African American Women","phase":"NA","status":"COMPLETED","role":"Overall official","sponsor":"Washington University School of Medicine","source_url":"https://clinicaltrials.gov/study/NCT05275361","trial_url":"https://www.findmykol.com/trial/NCT05275361"}],"source":"trials"},"payments":{"company_count":6,"program_years":{"first":2021,"last":null},"rows_total":14,"shown":3,"withheld":11,"rows":[{"payer":"AstraZeneca","program_year":2025,"amount_usd":169877.64,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1760832711"},{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2025,"amount_usd":2529.08,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1760832711"},{"payer":"Gilead Sciences, Inc.","program_year":2025,"amount_usd":727.22,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1760832711"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1760832711","source":"payments"},"prescribing":{"data_year":2024,"areas_total":6,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":64.9,"classes_total":3,"classes":[{"class":"Aromatase Inhibitor","setting":"prescribed","share_pct":52.2,"drugs":[{"name":"Anastrozole","share_pct":70.8},{"name":"Letrozole","share_pct":25.8},{"name":"Exemestane","share_pct":3.3}],"max_beneficiaries":null},{"class":"Estrogen Agonist/Antagonist","setting":"prescribed","share_pct":8.4,"drugs":[{"name":"Tamoxifen Citrate","share_pct":100}],"max_beneficiaries":21}]},{"area":"Nervous system","share_pct":17.5,"classes_total":4,"classes":[{"class":"Opioid Agonist","setting":"prescribed","share_pct":7.1,"drugs":[{"name":"Oxycodone Hcl","share_pct":31.6},{"name":"Fentanyl","share_pct":26.3},{"name":"Morphine Sulfate Er","share_pct":22.8},{"name":"Oxycodone-Acetaminophen","share_pct":19.3}],"max_beneficiaries":null},{"class":"SNRI","setting":"prescribed","share_pct":5.2,"drugs":[{"name":"Duloxetine Hcl","share_pct":57.1},{"name":"Venlafaxine Hcl Er","share_pct":42.9}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":9.8,"classes_total":5,"classes":[{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":3.6,"drugs":[{"name":"Ondansetron Hcl","share_pct":100}],"max_beneficiaries":14},{"class":"Proton pump inhibitor","setting":"prescribed","share_pct":1.8,"drugs":[{"name":"Omeprazole","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"mixed","data_year":2024,"office_pct":49.2,"facility_pct":50.8},"source":"medicare"},"publications":{"total":44,"shown":5,"withheld":39,"matched_by":"OpenAlex author record","recent":[{"title":"Evolving concepts in HER2-low breast cancer: Genomic insights, definitions, and treatment paradigms","year":2025,"journal":"Oncotarget","source_url":"https://doi.org/10.18632/oncotarget.28680","status":"verified"},{"title":"Impact of National Society Guidelines and National Comprehensive Cancer Network (NCCN) Guidelines on Genetic Testing Use Among Patients with Breast Cancer","year":2025,"journal":"Annals of Surgical Oncology","source_url":"https://doi.org/10.1245/s10434-025-17448-w","status":"verified"},{"title":"Abstract CT071: Phase I trial of trastuzumab deruxtecan in combination with neratinib in solid tumors with HER2 alterations (NCI 10495)","year":2025,"journal":"Cancer Research","source_url":"https://doi.org/10.1158/1538-7445.am2025-ct071","status":"verified"},{"title":"Genomic and proteomic profiling of GATA3 mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomes","year":2025,"journal":"Breast Cancer Research and Treatment","source_url":"https://doi.org/10.1007/s10549-025-07710-w","status":"verified"},{"title":"Abstract P2-05-21: BRCA1/2 alterations in circulating tumor DNA: correlation with germline origin and impact on survival in breast cancer","year":2025,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1557-3265.sabcs24-p2-05-21","status":"verified"}],"source":"works"},"contact":{"address_1":"4401 WORNALL RD","city":"Kansas City","state":"MO","zip":"641113220","phone":"816-932-5350","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1760832711","source":"identity"},"similar":[{"name":"Randall Bateman","slug":"randall-bateman","institution":"Washington University in St. Louis","specialty":"Neurology","url":"https://www.findmykol.com/kol/randall-bateman","json_url":"https://www.findmykol.com/kol/randall-bateman/profile.json"},{"name":"David Clifford","slug":"david-clifford","institution":"Washington University in St. Louis","specialty":"Neurology","url":"https://www.findmykol.com/kol/david-clifford","json_url":"https://www.findmykol.com/kol/david-clifford/profile.json"},{"name":"Janet McGill","slug":"janet-mcgill","institution":"Washington University in St. Louis","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/janet-mcgill","json_url":"https://www.findmykol.com/kol/janet-mcgill/profile.json"},{"name":"Robert Carney","slug":"robert-carney","institution":"Washington University in St. Louis","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/robert-carney","json_url":"https://www.findmykol.com/kol/robert-carney/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":11,"publications":39}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2022-06-15","provider_certified":"2022-06-15","collected_at":"2026-11-04T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}